Lepu Biopharma Co., Ltd. (2157.HK)
HKD 3.31
(0.91%)
HKD 3.31
(0.91%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 4.79 Million CNY | 100.68% |
| 2022 | -704.48 Million CNY | 30.22% |
| 2021 | -1 Billion CNY | -94.03% |
| 2020 | -520.35 Million CNY | -14.45% |
| 2019 | -454.65 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -99.72 Million HKD | 62.95% |
| 2024 Q2 | -98.87 Million HKD | 0.15% |
| 2023 Q3 | 65.85 Million HKD | 142.5% |
| 2023 FY | 4.79 Million CNY | 100.68% |
| 2023 Q4 | -274.51 Million HKD | -516.87% |
| 2023 Q2 | -154.94 Million HKD | -129.77% |
| 2023 Q1 | -67.43 Million HKD | 82.06% |
| 2022 FY | -704.48 Million CNY | 30.22% |
| 2022 Q2 | -340.55 Million HKD | 0.0% |
| 2022 Q4 | -375.98 Million HKD | 0.0% |
| 2021 FY | -1 Billion CNY | -94.03% |
| 2021 Q2 | -561.59 Million HKD | 0.0% |
| 2020 FY | -520.35 Million CNY | -14.45% |
| 2019 FY | -454.65 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 67.76 Million HKD | 92.923% |
| CK Life Sciences Int'l., (Holdings) Inc. | 897.95 Million HKD | 99.466% |